14.4002.04% ( -0.300 )
Delay Closed: Nov 16, 16:08:11Overview
QYUNS-B (2509)
Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseas...
- Open
- 14.420
- High
- 14.560
- Low
- 14.400
- Prev. Close
- 14.700
- Volume
- 30.00K
- Turnover
- 432.42K
- Avg Price
- 14.414
- Bid/Ask Ratio
- 77.78%
- Amplitude
- 1.09%
- 52wk High
- 24.500
- Volume Ratio
- 0.28
- Turnover Ratio
- 0.01%
- 52wk Low
- 13.210
- HK Mkt Cap
- 3.22B
- Market CapHKD
- 3.22B
- P/ETTM
- 5.12
- P/EDynamic
- 6.87
- P/EStatic
- --
- EPSTTM
- 2.81
- EPSDynamic
- 2.10
- EPSStatic
- --
- BVPS
- 4.44
- P/B
- 3.24
- HK Shares
- 223.37M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 223.37M
- Min lot size
- 200
- Currency
- HKD
QYUNS-B Analyst Rating
View moreForecast & Rating
Sep 21, 2026Price forecast
HK$33.00129.17%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
Qyuns Therapeutics closed up 3.84% at HKD 15.40 today, opening low and rallying to an intraday high of HKD 15.87, up over 7% from the previous close of HKD 14.83. Total turnover was approximately HKD 1.62 million with a turnover rate of 0.05%. Recent share buybacks at HKD 13.4-13.99, coupled with strong Q4 2025 results showing a 451% YoY revenue jump to HKD 334 million and a net profit of HKD 191 million (up 319% YoY), underpinned the rally. However, the stock remains 57.81% below its 52-week high of HKD 36.50 and below the 60-day MA of HKD 16.88, with a YTD decline of 21.35%.
